Literature DB >> 31823558

[Clinical application of modified kite flap in treatment of divided nevus of lateral canthus].

Shuwen Sheng1, Huicai Wen2, Jinjun Huang1, Jianhua Fu1, Yingjie Lu1, Huaiwei Liao1, Jun Tu1.   

Abstract

OBJECTIVE: To investigate the effectiveness of modified kite flap in repair of soft tissue defect after divided nevus of lateral canthus excision.
METHODS: Between October 2010 and April 2018, 20 children (20 eyes) with divided nevus of lateral canthus were admitted. There were 13 boys and 7 girls, with an average age of 7.9 years (mean, 4-14 years). There were 11 cases of moderate range lesions (maximum diameter, 1.5-2.0 cm) and 9 cases of small range lesions (maximum diameter, <1.5 cm). After excising the divided nevus of lateral canthus, the area of soft tissue defect ranged from 0.72 to 3.23 cm2。The modified kite flap was used to reconstruct the structure and shape of lateral canthus.
RESULTS: There were 16 cases of mixed nevus and 4 cases of intradermal nevus. The flaps survived and the incisions healed by the first intention. The patients were followed up 12-22 months (mean, 13.6 months). There was no malformation, valgus, exposure keratitis, or obvious scar. No malignant transformation occurred or nevus recurred during follow-up. At last follow-up, the effectiveness was rated as excellent in 16 cases, good in 3 cases, and poor in 1 case.
CONCLUSION: The modified kite flap can repair the soft tissue defect after excising the divided nevus of lateral canthus, and obtain the good appearance and function of lateral canthus.

Entities:  

Keywords:  Divided nevus of lateral canthus; cosmetic repair; lateral canthus reconstruction; modified kite flap

Mesh:

Year:  2019        PMID: 31823558      PMCID: PMC8355789          DOI: 10.7507/1002-1892.201905012

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  9 in total

1.  Bipedicled skin flap in the treatment of divided nevus of the eyelid.

Authors:  Jaehoon Choi; Yoonho Lee
Journal:  Dermatol Surg       Date:  2013-07-23       Impact factor: 3.398

2.  [Clinical research of sideburn reconstruction with expanded island scalp flap based on parietal branch of superficial temporal vessel].

Authors:  Longcan Liu; Yuanbo Liu; Mengqing Zang; Shan Zhu; Bo Chen; Shanshan Li
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2017-11-15

3.  Primary orbital melanoma combined with giant divided nevus of the eyelid.

Authors:  Yifeng Ke; Xinjun Ren; Liming Zhu; Rui Hao; Wenjin Song; Xun Liu; Yanjin He
Journal:  J Craniofac Surg       Date:  2014-01       Impact factor: 1.046

Review 4.  Divided nevus of the eyelid: review of embryology, pathology and treatment.

Authors:  Shaun C Desai; Scott Walen; John B Holds; Gregory Branham
Journal:  Am J Otolaryngol       Date:  2013-02-04       Impact factor: 1.808

5.  Role of amniotic membrane and full-thickness skin graft in reconstruction of kissing nevus of eyelids.

Authors:  Manpreet Singh; Natasha Gautam; Manpreet Kaur; Zoramthara Zadeng
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

6.  Reconstruction of a Large Divided Nevus of the Eyelid.

Authors:  Li Hu; Yunbo Jin; Mathias Tremp; Xiaoxi Lin
Journal:  Dermatol Surg       Date:  2017-12       Impact factor: 3.398

7.  Clinicopathological characteristics and surgical outcomes of divided nevus of the eyelids: a decade's experience on 73 cases.

Authors:  Renbing Jia; Huimin Zhu; Ming Lin; Zhengkang Li; Ying Sun; Min Luo; Xianqun Fan
Journal:  Ann Plast Surg       Date:  2012-02       Impact factor: 1.539

Review 8.  Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management.

Authors:  Zeina S Tannous; Martin C Mihm; Arthur J Sober; Lyn M Duncan
Journal:  J Am Acad Dermatol       Date:  2005-02       Impact factor: 11.527

Review 9.  Risk of melanoma arising in large congenital melanocytic nevi: a systematic review.

Authors:  Andrew J Watt; Sandra V Kotsis; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2004-06       Impact factor: 4.730

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.